Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page
- ChecktodayChange DetectedA site-wide funding notice banner was added, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov for updates. The page also shows a minor revision note: Revision: v3.4.1 replaces v3.4.0.SummaryDifference0.3%

- Check7 days agoChange DetectedUI and documentation updates: glossary now shown; labeling updated for QC criteria submission and FEAR Act data; site revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedLocations section added listing all study sites by state (Alabama, Arizona, California, Colorado, Connecticut, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Utah, Wisconsin) and HHS Vulnerability Disclosure removed; revision updated to v3.3.3.SummaryDifference1%

- Check65 days agoChange DetectedMinor metadata update: Revision v3.3.2 was added and v3.3.1 was removed; there are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedPublications section text updated to clarify entries are automatically filled from PubMed and may not reflect only the study content, and a revision label 'Revision: v3.3.1' was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.